IL156669A0 - 2-aminobenzoyl derivatives - Google Patents

2-aminobenzoyl derivatives

Info

Publication number
IL156669A0
IL156669A0 IL15666903A IL15666903A IL156669A0 IL 156669 A0 IL156669 A0 IL 156669A0 IL 15666903 A IL15666903 A IL 15666903A IL 15666903 A IL15666903 A IL 15666903A IL 156669 A0 IL156669 A0 IL 156669A0
Authority
IL
Israel
Prior art keywords
aminobenzoyl derivatives
aminobenzoyl
derivatives
Prior art date
Application number
IL15666903A
Other languages
English (en)
Original Assignee
Neurim Pharma 1991
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Neurim Pharma 1991 filed Critical Neurim Pharma 1991
Priority to IL15666903A priority Critical patent/IL156669A0/xx
Publication of IL156669A0 publication Critical patent/IL156669A0/xx
Priority to ARP040102095A priority patent/AR044786A1/es
Priority to PE2004000604A priority patent/PE20050230A1/es
Priority to PA20048605401A priority patent/PA8605401A1/es
Priority to UY28382A priority patent/UY28382A1/es
Priority to EA200600115A priority patent/EA011255B1/ru
Priority to PT04744907T priority patent/PT1644316E/pt
Priority to US10/562,197 priority patent/US8309767B2/en
Priority to HN2004000224A priority patent/HN2004000224A/es
Priority to MXPA06000022A priority patent/MXPA06000022A/es
Priority to BRPI0411382-9A priority patent/BRPI0411382A/pt
Priority to PL04744907T priority patent/PL1644316T3/pl
Priority to SI200431416T priority patent/SI1644316T1/sl
Priority to ZA200600640A priority patent/ZA200600640B/en
Priority to DE602004025937T priority patent/DE602004025937D1/de
Priority to NZ544908A priority patent/NZ544908A/en
Priority to AT04744907T priority patent/ATE460391T1/de
Priority to CN200480017943XA priority patent/CN1835910B/zh
Priority to AU2004249012A priority patent/AU2004249012B2/en
Priority to UAA200600303A priority patent/UA85187C2/ru
Priority to TW093118235A priority patent/TWI342210B/zh
Priority to KR1020057025006A priority patent/KR101115196B1/ko
Priority to EP04744907A priority patent/EP1644316B1/en
Priority to PCT/IL2004/000567 priority patent/WO2004112690A2/en
Priority to CA2527112A priority patent/CA2527112C/en
Priority to ES04744907T priority patent/ES2341958T3/es
Priority to JP2006516814A priority patent/JP4646907B2/ja
Priority to DK04744907.9T priority patent/DK1644316T3/da
Priority to IS8235A priority patent/IS8235A/is
Priority to NO20060420A priority patent/NO20060420L/no
Priority to HK07102168.5A priority patent/HK1094795A1/xx
Priority to CY20101100463T priority patent/CY1110043T1/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C225/00—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones
    • C07C225/22—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones having amino groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/132—Amines having two or more amino groups, e.g. spermidine, putrescine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/136—Amines having aromatic rings, e.g. ketamine, nortriptyline having the amino group directly attached to the aromatic ring, e.g. benzeneamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/36—Opioid-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C225/00—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones
    • C07C225/02—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones having amino groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C225/14—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones having amino groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being unsaturated
    • C07C225/16—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones having amino groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being unsaturated and containing six-membered aromatic rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Pain & Pain Management (AREA)
  • Hematology (AREA)
  • Reproductive Health (AREA)
  • Cardiology (AREA)
  • Psychiatry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Gynecology & Obstetrics (AREA)
  • Urology & Nephrology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Epidemiology (AREA)
  • Addiction (AREA)
  • Obesity (AREA)
  • Pregnancy & Childbirth (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Vascular Medicine (AREA)
  • Rheumatology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Anesthesiology (AREA)
  • Emergency Medicine (AREA)
IL15666903A 2003-06-26 2003-06-26 2-aminobenzoyl derivatives IL156669A0 (en)

Priority Applications (32)

Application Number Priority Date Filing Date Title
IL15666903A IL156669A0 (en) 2003-06-26 2003-06-26 2-aminobenzoyl derivatives
ARP040102095A AR044786A1 (es) 2003-06-26 2004-06-16 Derivados de 2- aminobenzoilo
PE2004000604A PE20050230A1 (es) 2003-06-26 2004-06-18 Derivados de 2 aminobenzoilo
PA20048605401A PA8605401A1 (es) 2003-06-26 2004-06-22 Derivados de 2-aminobenzoilo
UY28382A UY28382A1 (es) 2003-06-26 2004-06-23 Derivados de 2-aminobenzoilo
DK04744907.9T DK1644316T3 (da) 2003-06-26 2004-06-24 2-aminobenzoylderivater
DE602004025937T DE602004025937D1 (de) 2003-06-26 2004-06-24 2-aminobenzoylderivate
AU2004249012A AU2004249012B2 (en) 2003-06-26 2004-06-24 2-aminobenzoyl derivatives
US10/562,197 US8309767B2 (en) 2003-06-26 2004-06-24 2-aminobenzoyl derivatives
HN2004000224A HN2004000224A (es) 2003-06-26 2004-06-24 Derivados de 2 - aminobenzoilo
MXPA06000022A MXPA06000022A (es) 2003-06-26 2004-06-24 Derivados de 2-aminobenzoilo.
BRPI0411382-9A BRPI0411382A (pt) 2003-06-26 2004-06-24 derivados de 2-aminobenzoil
PL04744907T PL1644316T3 (pl) 2003-06-26 2004-06-24 Pochodne 2-aminobenzoilowe
SI200431416T SI1644316T1 (sl) 2003-06-26 2004-06-24 Derivati aminobenzoila
ZA200600640A ZA200600640B (en) 2003-06-26 2004-06-24 2-aminobenzoyl derivatives
EA200600115A EA011255B1 (ru) 2003-06-26 2004-06-24 Производные 2-аминобензойной кислоты
NZ544908A NZ544908A (en) 2003-06-26 2004-06-24 2-aminobenzoyl derivatives
AT04744907T ATE460391T1 (de) 2003-06-26 2004-06-24 2-aminobenzoylderivate
CN200480017943XA CN1835910B (zh) 2003-06-26 2004-06-24 2-氨基苯甲酰基衍生物
PT04744907T PT1644316E (pt) 2003-06-26 2004-06-24 Derivados de 2-aminobenzoílo
UAA200600303A UA85187C2 (en) 2003-06-26 2004-06-24 2-aminobenzoyl derivatives
TW093118235A TWI342210B (en) 2003-06-26 2004-06-24 2-aminobenzoyl derivatives
KR1020057025006A KR101115196B1 (ko) 2003-06-26 2004-06-24 2-아미노벤조일 유도체
EP04744907A EP1644316B1 (en) 2003-06-26 2004-06-24 2-aminobenzoyl derivatives
PCT/IL2004/000567 WO2004112690A2 (en) 2003-06-26 2004-06-24 2-aminobenzoyl derivatives
CA2527112A CA2527112C (en) 2003-06-26 2004-06-24 2-aminobenzoyl derivatives as nmda receptor antagonists
ES04744907T ES2341958T3 (es) 2003-06-26 2004-06-24 Derivados de 2-aminobenzoilo.
JP2006516814A JP4646907B2 (ja) 2003-06-26 2004-06-24 ２−アミノベンゾイル誘導体
IS8235A IS8235A (is) 2003-06-26 2006-01-16 2-amínóbensóýl afleiður
NO20060420A NO20060420L (no) 2003-06-26 2006-01-25 2-aminobenzoylderivater
HK07102168.5A HK1094795A1 (en) 2003-06-26 2007-02-27 2-aminobenzoyl derivatives
CY20101100463T CY1110043T1 (el) 2003-06-26 2010-05-25 2-αμινοβενζουλ παραγωγα

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IL15666903A IL156669A0 (en) 2003-06-26 2003-06-26 2-aminobenzoyl derivatives

Publications (1)

Publication Number Publication Date
IL156669A0 true IL156669A0 (en) 2004-01-04

Family

ID=32587677

Family Applications (1)

Application Number Title Priority Date Filing Date
IL15666903A IL156669A0 (en) 2003-06-26 2003-06-26 2-aminobenzoyl derivatives

Country Status (32)

Country Link
US (1) US8309767B2 (es)
EP (1) EP1644316B1 (es)
JP (1) JP4646907B2 (es)
KR (1) KR101115196B1 (es)
CN (1) CN1835910B (es)
AR (1) AR044786A1 (es)
AT (1) ATE460391T1 (es)
AU (1) AU2004249012B2 (es)
BR (1) BRPI0411382A (es)
CA (1) CA2527112C (es)
CY (1) CY1110043T1 (es)
DE (1) DE602004025937D1 (es)
DK (1) DK1644316T3 (es)
EA (1) EA011255B1 (es)
ES (1) ES2341958T3 (es)
HK (1) HK1094795A1 (es)
HN (1) HN2004000224A (es)
IL (1) IL156669A0 (es)
IS (1) IS8235A (es)
MX (1) MXPA06000022A (es)
NO (1) NO20060420L (es)
NZ (1) NZ544908A (es)
PA (1) PA8605401A1 (es)
PE (1) PE20050230A1 (es)
PL (1) PL1644316T3 (es)
PT (1) PT1644316E (es)
SI (1) SI1644316T1 (es)
TW (1) TWI342210B (es)
UA (1) UA85187C2 (es)
UY (1) UY28382A1 (es)
WO (1) WO2004112690A2 (es)
ZA (1) ZA200600640B (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1869002A (zh) * 2005-05-27 2006-11-29 中国科学院上海药物研究所 一类非甾体雄激素受体调节剂、其制备方法和用途
US7622495B2 (en) * 2006-10-03 2009-11-24 Neurim Pharmaceuticals (1991) Ltd. Substituted aryl-indole compounds and their kynurenine/kynuramine-like metabolites as therapeutic agents
JP2016501203A (ja) 2012-11-20 2016-01-18 バーテックス ファーマシューティカルズ インコーポレイテッドＶｅｒｔｅｘ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ Ｉｎｃｏｒｐｏｒａｔｅｄ インドールアミン２，３−ジオキシゲナーゼの阻害剤として有用な化合物
JP6664814B2 (ja) * 2014-08-18 2020-03-13 国立大学法人大阪大学 新規２−アミノベンゾイル誘導体
US11712425B2 (en) 2018-03-14 2023-08-01 Albert Einstein College Of Medicine Immunoregulatory role of 3-OH-kynurenamine and uses thereof
US11911376B2 (en) 2020-03-30 2024-02-27 The Regents Of The University Of Colorado Methods for preventing and treating retinal damage

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT305987B (de) 1969-12-18 1973-03-26 Degussa Verfahren zur Herstellung von neuen Aminoketonen
GB1334884A (en) * 1970-12-18 1973-10-24 Sumitomo Chemical Co Aminoalcohols and their conversion to aminoketones
JPS5336455B2 (es) * 1973-02-03 1978-10-03
US4018823A (en) 1976-04-20 1977-04-19 Morton-Norwich Products, Inc. 4',5'-Dimethoxy-2',3-diaminopropiophenone dihydrochloride
FR2569185B1 (fr) 1984-08-20 1986-09-05 Lafon Labor Derives de 1-(aminophenyl)-2-amino-ethanone, procede de preparation et utilisation en therapeutique

Also Published As

Publication number Publication date
ES2341958T3 (es) 2010-06-30
KR101115196B1 (ko) 2012-02-24
NZ544908A (en) 2009-11-27
PL1644316T3 (pl) 2010-08-31
CY1110043T1 (el) 2015-01-14
HK1094795A1 (en) 2007-04-13
CA2527112C (en) 2012-08-21
WO2004112690A2 (en) 2004-12-29
JP4646907B2 (ja) 2011-03-09
IS8235A (is) 2006-01-16
TW200503672A (en) 2005-02-01
ZA200600640B (en) 2007-05-30
PT1644316E (pt) 2010-06-02
BRPI0411382A (pt) 2006-09-19
AR044786A1 (es) 2005-10-05
PA8605401A1 (es) 2006-03-24
KR20060023581A (ko) 2006-03-14
PE20050230A1 (es) 2005-04-22
AU2004249012A1 (en) 2004-12-29
EP1644316A2 (en) 2006-04-12
CA2527112A1 (en) 2004-12-29
UY28382A1 (es) 2004-11-08
MXPA06000022A (es) 2006-07-06
WO2004112690B1 (en) 2005-05-19
CN1835910B (zh) 2010-09-29
US8309767B2 (en) 2012-11-13
HN2004000224A (es) 2007-12-21
DK1644316T3 (da) 2010-07-19
AU2004249012B2 (en) 2010-04-01
CN1835910A (zh) 2006-09-20
NO20060420L (no) 2006-01-25
TWI342210B (en) 2011-05-21
JP2007518673A (ja) 2007-07-12
EA200600115A1 (ru) 2008-06-30
EA011255B1 (ru) 2009-02-27
SI1644316T1 (sl) 2010-06-30
EP1644316A4 (en) 2006-10-25
DE602004025937D1 (de) 2010-04-22
EP1644316B1 (en) 2010-03-10
US20060270733A1 (en) 2006-11-30
WO2004112690A3 (en) 2005-03-17
ATE460391T1 (de) 2010-03-15
UA85187C2 (en) 2009-01-12

Similar Documents

Publication Publication Date Title
AP1850A (en) Spiroindolineplperidine derivatives
EG24050A (en) Heterocylocarboxamide derivatives
HK1088602A1 (en) 2-pyridinecarboxamide derivatives
HK1088326A1 (en) Piperidine-benzenesulfonamide derivatives
HK1089443A1 (en) Imidazol-4-yl-ethynyl-pyridine derivatives
GB0317665D0 (en) Qinazoline derivatives
HK1077068A1 (en) Azolidinone-vinyl fused-benzene derivatives
IL166121A0 (en) Indole-3-sulphur derivatives
EP1522540A4 (en) AZAARENE DERIVATIVES
SI1682493T1 (sl) Amidoacetonitrilni derivati
IL175189A0 (en) N-thiazol-2-yl-benzamide derivatives
TWI368482B (en) New 2-pyridinylethylbenzamide derivatives
IL166426A0 (en) N-biarylmethyl aminocycloalkanecarboxamide derivatives
HK1094795A1 (en) 2-aminobenzoyl derivatives
PL1706373T3 (pl) Pochodne amidoacetonitrylu
AU2003222659A8 (en) 23-o-substituted 5-o-mycaminosyltylonide derivatives
GB0312368D0 (en) Novel ureido- and amido-pyrazolone derivatives
GB0319793D0 (en) Pyridinylmorpholine derivatives
EP1531854A4 (en) O-DERIVATED NOCATHIACIN DERIVATIVES
GB0213488D0 (en) 2-Naphthamide derivatives
AU2003243397A8 (en) Homo-camptothecin derivatives
TWI341309B (en) Heteroarylcarbamoylbenzene derivatives
GB0319148D0 (en) Azaquinazoline derivatives
AU2003280822A8 (en) Beauveriolide derivatives
SI1654253T1 (sl) Substituirani 3-pirolidin-indolni derivati

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees